Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Early diagnosis of Keratosis pilaris atrophicans faciei can lead to better, personalized treatments.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dutasteride may help shrink prostate cancer tumors.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Finasteride causes reproductive malformations in male rats.

Finasteride may cause serious muscle-related side effects.

Mutations in the ST14 gene cause skin and hair issues by disrupting important protein processing.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.